Hopp til hovedinnhold
Sjøgrens syndrom rammer i 90 prosent av tilfellene kvinner.
Sjøgrens syndrom rammer i 90 prosent av tilfellene kvinner.

Sjøgrens syndrom

Sjøgrens syndrom er en betennelse som rammer kroppens kjertler og gir symptomer som tørr munn og tørre øyne. Mange pasienter har i tillegg uklare plager som leddsmerter, muskelsmerter og tretthet.

Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/muskelskjelett/giktsykdommer/sjogrens-syndrom/ 

Hva er Sjøgrens syndrom?

Symptomer

Årsak

Diagnostikk

Behandling

Prognose

Pasientorganisasjon

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Sjøgrens syndrom. Referanselisten for dette dokumentet vises nedenfor.

  1. Fox RI. Sjögren's syndrome. Lancet 2005; 366: 321-31. PubMed 
  2. Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician 2009; 79: 465-70. American Family Physician 
  3. Kurien BT, Scofield RH. Sjogren's syndrome. BMJ Best Practice, last updated May 23, 2016. bestpractice.bmj.com 
  4. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J and Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004; 33: 39-43. PubMed 
  5. Kabasakal Y, Kitapciglu G, Turk T, et al. The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol. 2006;35:379-383. PubMed 
  6. Pillemer SR, Matteson EL, Jacobsson LT et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County. Minnesota, Mayo Clin Proc 2001; 76: 593-9.
  7. Cimaz R, Casadei A, Rose C et al. Primary Sjögren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr 2003; 162: 661-5. PubMed 
  8. García-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002; 81: 270-80. PubMed 
  9. Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013;9:544-556. PubMed 
  10. Cummins MJ, Papas A, Kammer GM, Fox PC. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum 2003; 49: 585-93. PubMed 
  11. Mariette X, Ravaud P, Steinfeld S, et al. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum 2004; 50: 1270-6. PubMed 
  12. Manoussakis MN, Georgopoulou C, Zintzaras E et al. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum 2004; 50: 882-91. PubMed 
  13. Baer AN. Diagnosis and classification of Sjögren's syndrome. UpToDate, last updated Sep 11, 2018. www.uptodate.com 
  14. Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 2017; 69:35. PubMed 
  15. Mariette X, Criswell LA. Primary Sjögren’s Syndrome. N Engl J Med 2018; 378: 931-39. pmid:29514034 PubMed 
  16. Lwin CT, Bishay M, Platts RG, Booth DA and Bowman SJ. The assessment of fatigue in primary Sjögren's syndrome. Scand J Rheumatol 2003; 32: 33-7. PubMed 
  17. Lindvall B, Bengtsson A, Ernerudh J and Eriksson P. Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain. J Rheumatol 2002; 29: 717-25. PubMed 
  18. Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol 2015; 168:317. PubMed 
  19. Ramos-Casals M, Anaya JM, Garcia-Carrasco M et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004; 83: 96-106. PubMed 
  20. Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL and Youinou P. Cutaneous manifestations of primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol 2004; 22: 632-6. PubMed 
  21. Chung WS, Lin CL, Sung FC, et al. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study. J Rheumatol. 2014;41:909-915. PubMed 
  22. Gamron S, Barberis G, Onetti CM et al. Mesangial nephropathy in Sjögren's syndrome. Scand J Rheumatol 2000; 29; 65-7.
  23. Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K and Auvinen A. Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: a population-based study in Finland. Am J Med 2003; 115: 62-5. PubMed 
  24. D'Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P and Pennec YL. Thyroid dysfunction in primary Sjögren's syndrome: a long-term followup study. Arthritis Rheum 2003; 49: 804-9. PubMed 
  25. Delalande S, de Seze J, Fauchais AL et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83: 280-91. PubMed 
  26. Scofield AK, Radfar L, Ice JA, et al. Relation of sensory peripheral neuropathy in Sjogren syndrome to anti-Ro/SSA. J Clin Rheumatol. 2012;18:290-293. PubMed 
  27. Scheinfeld N. Sjogren syndrome and systemic lupus erythematosus are distinct conditions. Dermatol Online J. 2006;12:4. PubMed 
  28. Gran JT, Myklebust G. Diagnostikk av primært Sjögrens syndrom. Tidsskr Nor Lægeforen 2001; 121: 563-6. Tidsskrift for Den norske legeforening 
  29. Jonsson MV, Baldini C. Major salivary gland ultrasonography in the diagnosis of Sjogren’s syndrome - a place in the diagnostic criteria? Rheum Dis Clin North Am. 2016 Aug;42(3):501-17. PMID: 27431351. PubMed 
  30. Vivino FB, Gala I and Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002; 29: 938-44. PubMed 
  31. Baer AN, Vivino FB. Treatment of Sjögren's syndrome: Constitutional and non-sicca organ-based manifestations. UpToDate, last updated Apr 06, 2020. UpToDate 
  32. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch Intern Med 2004; 164: 1275-84. PubMed 
  33. Baer AN, Sankar V. Treatment of dry mouth and other non-ocular sicca symptoms in Sjögren's syndrome. UpToDate, last updated Jul 11, 2020. UpToDate 
  34. Belafsky PC and Postma GN. The laryngeal and esophageal manifestations of Sjögren's syndrome. Curr Rheumatol Rep 2003; 5: 297-303. PubMed 
  35. Wang SQ, Zhang LW, Wei P, Hua H. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord 2017; 18: 186. pmid:28499370 PubMed 
  36. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014; 160: 233-42. PMID: 24727841 PubMed 
  37. Bowman SJ, Everett CC, O`Dwyer JL, et al. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjogren`s Syndrome. Arthritis Rheumatol. 2017; 69: 1440-50. PMID: 28296257 PubMed 
  38. He J, Chen J, Miao M, et al. Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome A Randomized Clinical Trial. JAMA Netw Open 2022; 5: e2241451. doi:10.1001/jamanetworkopen.2022.41451 DOI 
  39. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 2337-44. PubMed 
  40. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002; 46: 741-7. PubMed 
  41. Vitali C. Classification criteria for Sjögren's syndrome. Ann Rheum Dis 2003; 62: 94-5. PubMed 
  42. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64:475. PubMed